{
  "zip": "M9W 5X2",
  "sector": "Healthcare",
  "fullTimeEmployees": 33,
  "longBusinessSummary": "Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.",
  "city": "Toronto",
  "phone": "416 798 3001",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.intellipharmaceutics.com",
  "maxAge": 1,
  "address1": "30 Worcester Road",
  "fax": "416 798 3007",
  "industry": "Biotechnology",
  "previousClose": 0.15745,
  "regularMarketOpen": 0.16,
  "twoHundredDayAverage": 0.14129497,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.1624,
  "navPrice": null,
  "averageDailyVolume10Day": 81812,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.15745,
  "fiftyDayAverage": 0.14666666,
  "trailingAnnualDividendRate": null,
  "open": 0.16,
  "averageVolume10days": 81812,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.937953,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.15,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 103801,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 3846249,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 49179,
  "priceToSalesTrailing12Months": 2.8819618,
  "dayLow": 0.15,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 103801,
  "fiftyTwoWeekHigh": 0.26,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.06,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.1624,
  "exchange": "PNK",
  "shortName": "INTELLIPHARMACEUTICS INTL INC",
  "longName": "Intellipharmaceutics International Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IPCIF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_23127248",
  "uuid": "5df9ea02-19b7-3f49-a70b-d1a637e4a17d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 3.643,
  "beta3Year": null,
  "profitMargins": -2.32426,
  "enterpriseToEbitda": -1.196,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 23678100,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.198,
  "sharesShort": 713995,
  "sharesPercentSharesOut": 0.0326,
  "fundFamily": null,
  "lastFiscalYearEnd": 1575072000,
  "heldPercentInstitutions": 0.04652,
  "netIncomeToCommon": -3101939,
  "trailingEps": -0.134,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.02456,
  "nextFiscalYearEnd": 1638230400,
  "mostRecentQuarter": 1598832000,
  "shortRatio": 0.39,
  "sharesShortPreviousMonthDate": 1548892800,
  "floatShares": 23088757,
  "enterpriseValue": 4861593,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1536883200,
  "lastSplitFactor": "1:10",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1551312000,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0335,
  "sharesShortPriorMonth": 211757,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.16,
  "logo_url": "https://logo.clearbit.com/intellipharmaceutics.com"
}